Suppr超能文献

金刚烷胺对大鼠和小鼠的低温效应机制。

The mechanism of the hypothermic effect of amantadine in rats and mice.

作者信息

Brown F, Davies J A, Redfern P H

出版信息

J Pharm Pharmacol. 1978 May;30(5):287-90. doi: 10.1111/j.2042-7158.1978.tb13231.x.

Abstract

Amantadine (25--100 mg kg-1, i.p.) given to rats at an ambient temperature of 4 degrees, or mice at 21 degrees, caused a marked fall in rectal temperature. Prior administration of pimozide (1--2 mg kg-1, s.c.) did not block hypothermia due to amantadine in rats or mice; in contrast, hypothermia due to apomorphine (2 mg kg-1, i.p.) and piribedil (10--40 mg kg-1, i.p.) in rats was blocked by pimozide pretreatment. Amphetamine (5 mg kg-1, i.p.) given 2 h after reserpine (2 mg kg-1, i.p.) caused a reversal of the hypothermic effect of reserpine in mice, but a reversal was not obtained with amantadine (50 mg kg-1, i.p.). Direct injection of amantadine (4--8 mg kg-1) into the cerebral ventricles (i.c.v.) of mice caused marked hypothermia which was not blocked by pimozide, but intravenous injection of the same dose of amantadine did not cause hypothermia. Rimantadine, a congener of amantadine but without anti-parkinsonian activity, also caused pimozide insensitive hypothermia in mice at doses of 50 mg kg-1, intraperitoneally or 2--4 mg kg-1, intracerebroventricularly. The main conclusion drawn from these results is that in causing hypothermia amantadine acts in the cns but not on dopamine receptors.

摘要

在4摄氏度环境温度下给大鼠腹腔注射金刚烷胺(25 - 100毫克/千克),或在21摄氏度环境温度下给小鼠腹腔注射金刚烷胺,会导致直肠温度显著下降。预先皮下注射匹莫齐特(1 - 2毫克/千克)不会阻断大鼠或小鼠因金刚烷胺引起的体温过低;相反,大鼠因阿扑吗啡(2毫克/千克,腹腔注射)和匹立地尔(10 - 40毫克/千克,腹腔注射)引起的体温过低会被匹莫齐特预处理所阻断。在利血平(2毫克/千克,腹腔注射)给药2小时后腹腔注射苯丙胺(5毫克/千克)可使小鼠利血平的体温过低效应逆转,但金刚烷胺(50毫克/千克,腹腔注射)则不能使其逆转。直接向小鼠脑室注射金刚烷胺(4 - 8毫克/千克)会引起显著的体温过低,且不受匹莫齐特阻断,但静脉注射相同剂量的金刚烷胺不会引起体温过低。金刚乙胺是金刚烷胺的同类物,但无抗帕金森病活性,腹腔注射50毫克/千克或脑室内注射2 - 4毫克/千克剂量时,也会使小鼠产生匹莫齐特不敏感的体温过低。从这些结果得出的主要结论是,金刚烷胺引起体温过低是通过作用于中枢神经系统而非多巴胺受体。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验